tru Independence’s MetLife MET Stock Holding History

tru Independence’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,135	Closed	-$298	–	639
2020 Q2	$298	Buy	8,135 +3,500	+76%	+$122K	0.04%	210
2020 Q1	$141	Hold	4,635	–	–	0.02%	226
2019 Q4	$141K	Buy	+4,635	New	+$224K	0.02%	279

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

tru Independence's MET Position: Q3 2020 in Review

tru Independence sold out of MetLife (MET) in Q3 2020, closing a stake of 8,135 shares — an estimated $298 sold.

tru Independence first reported a position in MET in Q4 2019 and held it in 3 quarters. The position peaked at $141K in Q4 2019. 961 funds tracked by Wall St. Rank hold MET as of Q3 2020.

tru Independence reported no remaining MetLife position as of Q3 2020 after selling out during the quarter.
tru Independence sold 8,135 MetLife shares in Q3 2020, an estimated $298.
tru Independence first reported a position in MetLife in Q4 2019 and held it in 3 quarters.
tru Independence's MetLife position peaked at $141K in Q4 2019.
961 funds tracked by Wall St. Rank held MetLife as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.